Laneige Triple Sunscreen (AMOREPACIFIC)
Welcome to the PulseAid listing for the Laneige Triple Sunscreen drug offered from AMOREPACIFIC. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: | AMOREPACIFIC |
NON-PROPRIETARY NAME: | AVOBENZONE, OCTISALATE, HOMOSALATE, and OCTOCRYLENE |
SUBSTANCE NAME: | AVOBENZONE; OCTISALATE; HOMOSALATE; OCTOCRYLENE |
TYPE: | HUMAN OTC DRUG |
PHARMA CLASS: | |
ROUTE: | TOPICAL |
DOSAGE FORM: | CREAM |
MARKETING CATEGORY NAME: | OTC MONOGRAPH NOT FINAL |
START MARKETING DATE: | 2014-11-20 |
END MARKETING DATE: | 0000-00-00 |
Laneige Triple Sunscreen HUMAN OTC DRUG Details:
Item Description | Laneige Triple Sunscreen from AMOREPACIFIC |
LABELER NAME: | AMOREPACIFIC |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 1500; 2250; 4500; 4500(mg/50mL; mg/50mL; mg/50mL; mg/50mL) |
START MARKETING DATE: | 2014-11-20 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 43419-765_cba8b903-850f-4160-a396-67c8cec8bc2d |
PRODUCT NDC: | 43419-765 |
APPLICATION NUMBER: | part352 |
Other AVOBENZONE; OCTISALATE; HOMOSALATE; OCTOCRYLENE Pharmaceutical Manufacturers / Labelers: